Template:ACLS Narrow Irregular Tachycardia - Revision history

Ostermayer: Prepared the page for translation

2026-01-18T02:01:22Z

Prepared the page for translation

← Revisión anterior		Revisión del 02:01 18 ene 2026
Línea 1:		Línea 1:
	===[[Narrow complex tachycardia\|Narrow ''Irregular'' Tachycardia]]===		<languages/>
	*[[Multi-focal atrial tachycardia]] (MAT)		<translate>

			===[[Special:MyLanguage/Narrow complex tachycardia\|Narrow ''Irregular'' Tachycardia]]===

			*[[Special:MyLanguage/Multi-focal atrial tachycardia\|Multi-focal atrial tachycardia]] (MAT)
	**Treat underlying cause (hypokalemia, hypomagnesemia)		**Treat underlying cause (hypokalemia, hypomagnesemia)
	**Consider [[diltiazem]]		**Consider [[Special:MyLanguage/diltiazem\|diltiazem]]
	**Avoid beta blockers unless they are already known to be tolerated, as airway disease often co-morbid		**Avoid beta blockers unless they are already known to be tolerated, as airway disease often co-morbid
	**If not symptomatic and rate < 110/120 bpm, may not require treatment (e.g., patient with MAT secondary to COPD)		**If not symptomatic and rate < 110/120 bpm, may not require treatment (e.g., patient with MAT secondary to COPD)
	*[[Sinus tachycardia]] with frequent [[PACs]]		*[[Special:MyLanguage/Sinus tachycardia\|Sinus tachycardia]] with frequent [[Special:MyLanguage/PACs\|PACs]]
	**Treat underlying cause		**Treat underlying cause
	*[[A fib]] / [[A Flutter]] with variable conduction (see also [[Atrial Fibrillation with RVR]])		*[[Special:MyLanguage/A fib\|A fib]] / [[Special:MyLanguage/A Flutter\|A Flutter]] with variable conduction (see also [[Special:MyLanguage/Atrial Fibrillation with RVR\|Atrial Fibrillation with RVR]])
	**Check if patient has taken usual rate-control meds		**Check if patient has taken usual rate-control meds
	***If missed dose, may provide dose of home medication and observe for resolution		***If missed dose, may provide dose of home medication and observe for resolution
	**Determine whether patient is better candidate for rate control or rhythm control <ref>Frankel, G. et al. (2013) Rate versus rhythm control in atrial fibrillation. Canadian Family Physician 59(2), 161 - 168</ref>		**Determine whether patient is better candidate for rate control or rhythm control <ref>Frankel, G. et al. (2013) Rate versus rhythm control in atrial fibrillation. Canadian Family Physician 59(2), 161 - 168</ref>
	***Rate control preferred with:		***Rate control preferred with:
	****Persistent [[A fib]]		****Persistent [[Special:MyLanguage/A fib\|A fib]]
	****Less symptomatic patients		****Less symptomatic patients
	****Age 65 or older		****Age 65 or older
Línea 20:		Línea 24:
	****Patient preference		****Patient preference
	***Rhythm control preferred with:		***Rhythm control preferred with:
	****Paroxysmal or new [[A fib]]		****Paroxysmal or new [[Special:MyLanguage/A fib\|A fib]]
	****More symptomatic patients		****More symptomatic patients
	****Age < 65 years		****Age < 65 years
	****Heart failure clearly exacerbated by [[A fib]]		****Heart failure clearly exacerbated by [[Special:MyLanguage/A fib\|A fib]]
	****No history of rhythm control failure		****No history of rhythm control failure
	****Patient preference		****Patient preference
	**Rate control with:		**Rate control with:
	***[[Diltiazem]]		***[[Special:MyLanguage/Diltiazem\|Diltiazem]]
	***[[Metoprolol]]		***[[Special:MyLanguage/Metoprolol\|Metoprolol]]
	***[[Amiodarone]] (good in setting of hypotension, CHF)		***[[Special:MyLanguage/Amiodarone\|Amiodarone]] (good in setting of hypotension, CHF)
	***[[Digoxin]] (good in setting of CHF)		***[[Special:MyLanguage/Digoxin\|Digoxin]] (good in setting of CHF)
	**Rhythm conversion with:		**Rhythm conversion with:
	***Synchronized [[Cardioversion]] (120-200 J)		***Synchronized [[Special:MyLanguage/Cardioversion\|Cardioversion]] (120-200 J)
	****Best performed on patients with new onset [[A fib]] or patients fully therapeutically anti-coagulated for > 3 weeks		****Best performed on patients with new onset [[Special:MyLanguage/A fib\|A fib]] or patients fully therapeutically anti-coagulated for > 3 weeks
	***[[Procainamide]] per [[EBQ:Ottawa Aggressive ED Cardioversion Protocol\|Ottawa Aggressive ED Cardioversion Protocol]]		***[[Special:MyLanguage/Procainamide\|Procainamide]] per [[Special:MyLanguage/EBQ:Ottawa Aggressive ED Cardioversion Protocol\|Ottawa Aggressive ED Cardioversion Protocol]]
			</translate>

Rossdonaldson1: /* Narrow Irregular Tachycardia */

2025-07-30T17:10:00Z

Narrow Irregular Tachycardia

← Revisión anterior		Revisión del 17:10 30 jul 2025
Línea 7:		Línea 7:
	*[[Sinus tachycardia]] with frequent [[PACs]]		*[[Sinus tachycardia]] with frequent [[PACs]]
	**Treat underlying cause		**Treat underlying cause
	*[[A fib]] / A Flutter with variable conduction (see also [[Atrial Fibrillation with RVR]])		*[[A fib]] / [[A Flutter]] with variable conduction (see also [[Atrial Fibrillation with RVR]])
	**Check if patient has taken usual rate-control meds		**Check if patient has taken usual rate-control meds
	***If missed dose, may provide dose of home medication and observe for resolution		***If missed dose, may provide dose of home medication and observe for resolution

Rossdonaldson1: /* Narrow Irregular Tachycardia */

2025-07-30T17:08:40Z

Narrow Irregular Tachycardia

← Revisión anterior		Revisión del 17:08 30 jul 2025
Línea 5:		Línea 5:
	**Avoid beta blockers unless they are already known to be tolerated, as airway disease often co-morbid		**Avoid beta blockers unless they are already known to be tolerated, as airway disease often co-morbid
	**If not symptomatic and rate < 110/120 bpm, may not require treatment (e.g., patient with MAT secondary to COPD)		**If not symptomatic and rate < 110/120 bpm, may not require treatment (e.g., patient with MAT secondary to COPD)
	*[[Sinus tachycardia]] with frequent PACs		*[[Sinus tachycardia]] with frequent [[PACs]]
	**Treat underlying cause		**Treat underlying cause
	*[[A fib]] / A Flutter with variable conduction (see also [[Atrial Fibrillation with RVR]])		*[[A fib]] / A Flutter with variable conduction (see also [[Atrial Fibrillation with RVR]])

Rossdonaldson1: /* Narrow Irregular Tachycardia */

2025-07-30T17:08:12Z

Narrow Irregular Tachycardia

← Revisión anterior		Revisión del 17:08 30 jul 2025
Línea 5:		Línea 5:
	**Avoid beta blockers unless they are already known to be tolerated, as airway disease often co-morbid		**Avoid beta blockers unless they are already known to be tolerated, as airway disease often co-morbid
	**If not symptomatic and rate < 110/120 bpm, may not require treatment (e.g., patient with MAT secondary to COPD)		**If not symptomatic and rate < 110/120 bpm, may not require treatment (e.g., patient with MAT secondary to COPD)
	*Sinus ~~Tachycardia~~ with frequent PACs		*[[Sinus tachycardia]] with frequent PACs
	**Treat underlying cause		**Treat underlying cause
	*[[A fib]] / A Flutter with variable conduction (see also [[Atrial Fibrillation with RVR]])		*[[A fib]] / A Flutter with variable conduction (see also [[Atrial Fibrillation with RVR]])

Rossdonaldson1: /* Narrow Irregular Tachycardia */

2025-07-30T17:07:49Z

Narrow Irregular Tachycardia

← Revisión anterior		Revisión del 17:07 30 jul 2025
Línea 1:		Línea 1:
	===[[Narrow complex tachycardia\|Narrow ''Irregular'' Tachycardia]]===		===[[Narrow complex tachycardia\|Narrow ''Irregular'' Tachycardia]]===
	*Multi-focal atrial tachycardia (MAT)		*[[Multi-focal atrial tachycardia]] (MAT)
	**Treat underlying cause (hypokalemia, hypomagnesemia)		**Treat underlying cause (hypokalemia, hypomagnesemia)
	**Consider [[diltiazem]]		**Consider [[diltiazem]]

Rossdonaldson1: /* Narrow Irregular Tachycardia */

2025-07-30T17:02:41Z

Narrow Irregular Tachycardia

← Revisión anterior		Revisión del 17:02 30 jul 2025
Línea 12:		Línea 12:
	**Determine whether patient is better candidate for rate control or rhythm control <ref>Frankel, G. et al. (2013) Rate versus rhythm control in atrial fibrillation. Canadian Family Physician 59(2), 161 - 168</ref>		**Determine whether patient is better candidate for rate control or rhythm control <ref>Frankel, G. et al. (2013) Rate versus rhythm control in atrial fibrillation. Canadian Family Physician 59(2), 161 - 168</ref>
	***Rate control preferred with:		***Rate control preferred with:
	****Persistent A fib		****Persistent [[A fib]]
	****Less symptomatic patients		****Less symptomatic patients
	****Age 65 or older		****Age 65 or older
Línea 20:		Línea 20:
	****Patient preference		****Patient preference
	***Rhythm control preferred with:		***Rhythm control preferred with:
	****Paroxysmal or new A fib		****Paroxysmal or new [[A fib]]
	****More symptomatic patients		****More symptomatic patients
	****Age < 65 years		****Age < 65 years
	****Heart failure clearly exacerbated by A fib		****Heart failure clearly exacerbated by [[A fib]]
	****No history of rhythm control failure		****No history of rhythm control failure
	****Patient preference		****Patient preference
Línea 33:		Línea 33:
	**Rhythm conversion with:		**Rhythm conversion with:
	***Synchronized [[Cardioversion]] (120-200 J)		***Synchronized [[Cardioversion]] (120-200 J)
	****Best performed on patients with new onset A fib or patients fully therapeutically anti-coagulated for > 3 weeks		****Best performed on patients with new onset [[A fib]] or patients fully therapeutically anti-coagulated for > 3 weeks
	***[[Procainamide]] per [[EBQ:Ottawa Aggressive ED Cardioversion Protocol\|Ottawa Aggressive ED Cardioversion Protocol]]		***[[Procainamide]] per [[EBQ:Ottawa Aggressive ED Cardioversion Protocol\|Ottawa Aggressive ED Cardioversion Protocol]]

Sean839: /* Narrow Irregular Tachycardia */

2024-11-22T15:11:07Z

Narrow Irregular Tachycardia

← Revisión anterior		Revisión del 15:11 22 nov 2024
Línea 20:		Línea 20:
	****Patient preference		****Patient preference
	***Rhythm control preferred with:		***Rhythm control preferred with:
	****~~Paroxismal~~ or new A fib		****Paroxysmal or new A fib
	****More symptomatic patients		****More symptomatic patients
	****Age < 65 years		****Age < 65 years

Rossdonaldson1: /* Narrow Irregular Tachycardia */

2019-04-05T04:24:23Z

Narrow Irregular Tachycardia

← Revisión anterior		Revisión del 04:24 5 abr 2019
Línea 34:		Línea 34:
	***Synchronized [[Cardioversion]] (120-200 J)		***Synchronized [[Cardioversion]] (120-200 J)
	****Best performed on patients with new onset A fib or patients fully therapeutically anti-coagulated for > 3 weeks		****Best performed on patients with new onset A fib or patients fully therapeutically anti-coagulated for > 3 weeks
	***Procainamide [[EBQ:Ottawa Aggressive ED Cardioversion Protocol\|Ottawa Aggressive ED Cardioversion Protocol]]		***[[Procainamide]] per [[EBQ:Ottawa Aggressive ED Cardioversion Protocol\|Ottawa Aggressive ED Cardioversion Protocol]]

Rossdonaldson1 at 04:24, 5 April 2019

2019-04-05T04:24:01Z

← Revisión anterior		Revisión del 04:24 5 abr 2019
Línea 34:		Línea 34:
	***Synchronized [[Cardioversion]] (120-200 J)		***Synchronized [[Cardioversion]] (120-200 J)
	****Best performed on patients with new onset A fib or patients fully therapeutically anti-coagulated for > 3 weeks		****Best performed on patients with new onset A fib or patients fully therapeutically anti-coagulated for > 3 weeks
	***Procainamide [[Ottawa Aggressive ED Cardioversion Protocol]]		***Procainamide [[EBQ:Ottawa Aggressive ED Cardioversion Protocol\|Ottawa Aggressive ED Cardioversion Protocol]]

SLuckettG: /* Narrow Irregular Tachycardia */

2019-03-11T21:11:04Z

Narrow Irregular Tachycardia

← Revisión anterior		Revisión del 21:11 11 mar 2019
Línea 2:		Línea 2:
	*Multi-focal atrial tachycardia (MAT)		*Multi-focal atrial tachycardia (MAT)
	**Treat underlying cause (hypokalemia, hypomagnesemia)		**Treat underlying cause (hypokalemia, hypomagnesemia)
			**Consider [[diltiazem]]
			**Avoid beta blockers unless they are already known to be tolerated, as airway disease often co-morbid
	**If not symptomatic and rate < 110/120 bpm, may not require treatment (e.g., patient with MAT secondary to COPD)		**If not symptomatic and rate < 110/120 bpm, may not require treatment (e.g., patient with MAT secondary to COPD)
	*Sinus Tachycardia with frequent PACs		*Sinus Tachycardia with frequent PACs